Nguyen Doreen N, Kawamoto Satomi, Cimino-Mathews Ashley, Illei Peter B, Rosenthal Dorothy L, VandenBussche Christopher J
Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
Department of Radiology, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
Diagn Cytopathol. 2015 Oct;43(10):844-9. doi: 10.1002/dc.23321. Epub 2015 Aug 3.
Metaplastic squamous cell carcinoma (SCC) of the breast is a rare type of breast cancer. Metastases to the lung, which can be a major site of second primary tumor development among breast cancer patients, are difficult to distinguish from primary SCC of the lung and present a unique challenge for pathologists. There are few available discriminating immunohistochemical markers as squamous differentiation typically leads to loss of expression of characteristic primary epithelial cell markers of both breast and lung origin. GATA protein binding 3 (GATA-3) is a useful marker of breast origin in metastatic ductal and lobular carcinomas including poorly differentiated triple-negative carcinomas and some metaplastic carcinomas. Here, we present a case of metastatic SCC presenting as a solitary lung mass with regional lymph node metastases and a single satellite lesion in a patient with a history of metaplastic SCC of the breast. In addition to the routine markers of squamous differentiation, the metastases were also positive for estrogen receptor (ER) and GATA-3 on cytologic material obtained by transbronchial FNA. This suggests that immunoreactivity for ER and GATA-3 may support a diagnosis of metastatic SCC in the context of a prior metaplastic SCC of the breast.
乳腺化生性鳞状细胞癌(SCC)是一种罕见的乳腺癌类型。肺转移在乳腺癌患者中可能是第二原发性肿瘤发生的主要部位,难以与原发性肺SCC区分,给病理学家带来了独特的挑战。由于鳞状分化通常会导致乳腺和肺来源的特征性原发性上皮细胞标志物表达缺失,因此可用的鉴别免疫组化标志物很少。GATA结合蛋白3(GATA-3)是转移性导管癌和小叶癌(包括低分化三阴性癌和一些化生性癌)中乳腺来源的有用标志物。在此,我们报告一例转移性SCC病例,该病例表现为孤立性肺肿块伴区域淋巴结转移及单个卫星灶,患者有乳腺化生性SCC病史。除了常规的鳞状分化标志物外,通过经支气管细针穿刺活检获取的细胞学材料上的转移灶对雌激素受体(ER)和GATA-3也呈阳性。这表明在既往有乳腺化生性SCC的情况下,ER和GATA-3的免疫反应性可能支持转移性SCC的诊断。